Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-04-06FDA Approved: TICAGRELOR — Original Application (Oryza Pharmaceuticals, Inc.)
FDA approved the original application for ticagrelor by Oryza Pharmaceuticals, Inc., authorizing a generic ticagrelor product. Ticagrelor is…
-
FDA approval · 2020-03-19FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Italfarmaco SpA)
FDA approved a supplemental application for ENOXAPARIN SODIUM submitted by Italfarmaco SpA.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS [Phase 4]
A Phase 4 trial evaluating whether very low-dose rivaroxaban added to dual antiplatelet therapy improves thrombotic status in acute coronary…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Treatment of Depression in Acute Coronary Syndrome (ACS) Patients [NA]
Clinical trial evaluating treatment of depression in patients with acute coronary syndrome has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: PRESSUREwire Study
Clinical trial update for the PRESSUREwire study completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-05FDA Approved: TICAGRELOR — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Ticagrelor from Hisun Pharmaceuticals USA, Inc., confirming approval of the generic ticagrel…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence [NA]
A completed clinical trial evaluating a hybrid effectiveness-implementation approach to improve adherence to clopidogrel in patients with ca…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes [NA]
A completed clinical trial assessing depression identification following acute coronary syndrome, focusing on quality of life and cost outco…
-
FDA approval · 2019-12-13FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for Clopidogrel Bisulfate from Radha Pharmaceuticals, Inc., confirming approval of their generic pro…
-
EMA approval · 2019-11-13EMA Authorised: Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) (clopidogrel;acetylsalicylic acid) — Sanofi-Aventis Groupe
European Medicines Agency authorised a clopidogrel and acetylsalicylic acid combination product (Zentiva/DuoCover) for acute coronary syndro…
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Positive Psychology for Acute Coronary Syndrome Patients [NA]
Clinical trial completed evaluating positive psychology interventions for patients with acute coronary syndrome; results posted in 2019.
-
FDA approval · 2019-11-06FDA Approved: CLOPIDOGREL — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for clopidogrel under ANDA090844, finalizing an approval for its gen…
-
FDA approval · 2019-11-04FDA Approved: PRASUGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application from Aurobindo Pharma Limited for prasugrel, providing a generic version of the antiplatelet drug us…
-
FDA approval · 2019-11-04FDA Approved: PRASUGREL — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for prasugrel (generic) under ANDA205987, granting approval for the generic prasug…
-
FDA approval · 2019-11-04FDA Approved: PRASUGREL — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for prasugrel, granting approval of a generic prasugrel product.
-
FDA approval · 2019-10-23FDA Approved: KENGREAL — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for KENGREAL (cangrelor) submitted by Chiesi USA, Inc., authorizing the changes included in the supp…
-
FDA approval · 2019-10-01FDA Approved: BIVALIRUDIN — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories Limited's supplemental application for Bivalirudin, a generic anticoagulant, under an ANDA. The approv…
-
CLINICAL_TRIALS research · 2019-10-01Clinical Trial Update: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study [Phase 4]
A Phase 4 trial update assessing affordability and real-world effectiveness of antiplatelet treatment after myocardial infarction.
-
FDA approval · 2019-09-23FDA Approved: BIVALIRUDIN — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Bivalirudin submitted by Mylan Institutional LLC.
-
FDA approval · 2019-09-23FDA Approved: BIVALIRUDIN — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for bivalirudin by Meitheal Pharmaceuticals, marking regulatory approval of a modification to the dr…
-
FDA approval · 2019-09-20FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for clopidogrel bisulfate manufactured by Aurobindo Pharma Limited, enabling continued marketing…
-
FDA approval · 2019-09-12FDA Approved: CLOPIDOGREL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for clopidogrel from Amneal Pharmaceuticals LLC under ANDA 203751, confirming changes to the approve…
-
CLINICAL_TRIALS research · 2019-09-09Clinical Trial Update: Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia [Phase 4]
A Phase 4 trial evaluating the effect of alirocumab on coronary atheroma volume in Japanese patients hospitalized for acute coronary syndrom…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation [NA]
Completed clinical trial evaluating home-based training with telemonitoring guidance for low to moderate risk patients entering cardiac reha…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention [Phase 4]
Phase 4 trial update exploring a lower maintenance dose of ticagrelor in acute coronary syndrome patients undergoing percutaneous coronary i…